Trials / Terminated
TerminatedNCT01036724
Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation
Comparative Study of Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 107 (actual)
- Sponsor
- Biosense Webster, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the change in median radiation exposure time and median procedure time following guided radiofrequency (RF) ablation among subjects undergoing treatment for paroxysmal atrial fibrillation with either the CARTO® 3 or the NavX(TM) System. It is hypothesized that described features will reduce the median radiation exposure during the CARTO® 3 system-guided procedures compared to the NavX(TM) system-guided procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cardiac Mapping | Generating a cardiac map using the study device (CARTO 3) compared to the control device (NAVX\[TM\]) and measuring the amount of radiation exposure duration for each. |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-25
- First posted
- 2009-12-21
- Last updated
- 2017-09-27
- Results posted
- 2014-07-21
Locations
6 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01036724. Inclusion in this directory is not an endorsement.